[ SBML Homepage | Home ]
(misc header text)


Fallahi-Sichani M, Flynn JL, Linderman JJ, Kirschner DE, Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability and not apoptotic and cytolytic activities, J. Immunology, 2012, The Journal of Immunology, April 1, vol. 188, no. 7, pp. 3169-3178, DOI: doi:10.4049/jimmunol.1103298, PMID: 22379032, PMCID: 352958

TNFmechanism.xml.zip,


(Next text entry)


[ SBML Homepage | Home ]

(misc footer text)